Autolomous
PrivateLast Round
Accelerator
May 29, 2024
Total Funding Raised
$2.47M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Autolomous operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was an Accelerator round in May 2024.
Autolomous is a software company that provides a digital manufacturing management platform for cell and gene therapy developers and manufacturers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Pharma Supply Chain, Quality Management, Workflow Automation, Vertical SaaS
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Autolomous Comparables
Compare Autolomous with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| TrakCel | 86% | |
| Leucine | 78% | |
| Apprentice | 78% |
For institutional investors. Book with your work email.
Autolomous Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | May 29, 2024 | ||||
| Grant | Jun 12, 2023 | ||||
| Early Funding | Dec 27, 2022 | ||||
| Grant | Jul 27, 2021 | ||||
| Debt | May 4, 2021 | ||||
Seed | Aug 5, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Autolomous Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| UKRI Innovate UK | Debt, Grant |
| BioTools Innovator | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Grew 18% QoQ, from 34 to 40 employees.
- May 14, 2026
Monthly visitors increased 86% MoM, reaching 4K.
For institutional investors. Book with your work email.
Autolomous Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Autolomous's valuation, stock price, and market status.
Is Autolomous a public or private company?
Autolomous is a private company.
What is the current stock price of Autolomous?
Autolomous is a private company, so its shares have no public market price. Caplight tracks Autolomous's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Autolomous worth (valuation)?
Valuation information for Autolomous is not publicly available.
Can I buy Autolomous stock?
Autolomous shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Autolomous's last funding round?
Autolomous's most recent funding round was Accelerator on May 29, 2024.
Who are the main investors in Autolomous?
Key investors in Autolomous include UKRI Innovate UK.
Will Autolomous IPO soon?
No public IPO plans have been announced for Autolomous.
How can I track Autolomous secondary market activity?
Caplight tracks bids, offers, and trades in Autolomous's shares on secondary markets.